Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gugliotta

Showing results (61-70 of 469) with videos related to

Pageof 47
Sort By:
Cancer Treatment Reviews|August 16, 2011
Physician's guide to the clinical management of adverse events on nilotinib therapy for the treatment of CMLGianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, et al.
Aging|December 29, 2011
Imatinib in chronic myeloid leukemia elderly patientsGabriele Gugliotta, Fausto Castagnetti, Francesca Palandri, et al.
British Journal of Cancer|October 1, 1986
The immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breastG Bussolati, P Gugliotta, I Morra, et al.
Fungal Biology|August 14, 2016
Extensive characterization of the new genus Rickiopora (Polyporales)Mauro C Westphalen, Mario Rajchenberg, Michal Tomšovský, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1980
Defibrination in adult acute lymphoblastic leukaemia. Report of four casesA Guarini, M Baccarani, G Corbelli, et al.
Expert Review of Hematology|March 27, 2014
Definition and treatment of resistance to tyrosine kinase inhibitors in chronic myeloid leukemiaMichele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.
Actas Urologicas Espanolas|March 13, 2010
[Extracorporeal lithotripsy in children - the efficacy and long-term evaluation of renal parenchyma damage by DMSA-99mTc scintigraphy]L O Reis, E L Zani, O Ikari, et al.
Histopathology|January 7, 1998
Retrieved endogenous biotin: a novel marker and a potential pitfall in diagnostic immunohistochemistryG Bussolati, P Gugliotta, M Volante, et al.
Cancer Research|March 15, 1992
Tumor types derived from epithelial and myoepithelial cell lines of R3230AC rat mammary carcinomaA Sapino, M Papotti, B Sanfilippo, et al.
Hemasphere|March 21, 2022
Current treatment approaches in CMLFausto Castagnetti, Gabriele Gugliotta, Simona Soverini, et al.
Pageof 47

Showing results (61-70 of 469) with videos related to

Sort By:
Pageof 47
Cancer Treatment Reviews|August 16, 2011
Physician's guide to the clinical management of adverse events on nilotinib therapy for the treatment of CMLGianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, et al.
Aging|December 29, 2011
Imatinib in chronic myeloid leukemia elderly patientsGabriele Gugliotta, Fausto Castagnetti, Francesca Palandri, et al.
British Journal of Cancer|October 1, 1986
The immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breastG Bussolati, P Gugliotta, I Morra, et al.
Fungal Biology|August 14, 2016
Extensive characterization of the new genus Rickiopora (Polyporales)Mauro C Westphalen, Mario Rajchenberg, Michal Tomšovský, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1980
Defibrination in adult acute lymphoblastic leukaemia. Report of four casesA Guarini, M Baccarani, G Corbelli, et al.
Expert Review of Hematology|March 27, 2014
Definition and treatment of resistance to tyrosine kinase inhibitors in chronic myeloid leukemiaMichele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.
Actas Urologicas Espanolas|March 13, 2010
[Extracorporeal lithotripsy in children - the efficacy and long-term evaluation of renal parenchyma damage by DMSA-99mTc scintigraphy]L O Reis, E L Zani, O Ikari, et al.
Histopathology|January 7, 1998
Retrieved endogenous biotin: a novel marker and a potential pitfall in diagnostic immunohistochemistryG Bussolati, P Gugliotta, M Volante, et al.
Cancer Research|March 15, 1992
Tumor types derived from epithelial and myoepithelial cell lines of R3230AC rat mammary carcinomaA Sapino, M Papotti, B Sanfilippo, et al.
Hemasphere|March 21, 2022
Current treatment approaches in CMLFausto Castagnetti, Gabriele Gugliotta, Simona Soverini, et al.
Pageof 47